로딩 중…
지수 로딩 중…
Obsidian Therapeutics Inc. Common Stock
OBX· NASDAQ· Health Care
$17.00-1.90%
2026-09-22
Valuation Metrics
Obsidian Therapeutics Inc. Common Stock's Market Cap is $18M. Ranked #3113 of 3,119 in US market (top 100%), #1459 of 1,464 on NASDAQ (top 100%) by Market Cap.
Investment Metrics(as of 2026-09-22)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $18M | US#3,113/3,119 |
| Employees | 3 | US#2,806/3,119 |
| Performance | ||
| 1M Return | -14.57% | US#2,651/3,119 |
| From 52W High | -65.98% | US#2,973/3,119 |
| 1Y MDD | -53.43% | US#2,588/3,119 |
| Trading | ||
| Volume | 1,150,218 shares | US#1,309/3,119 |
| Trading Value | $20M | US#1,890/3,119 |
Company Info
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.